Starling OncologySTLN
13F holders, Q4 2024 (December 31)31holders −3
5new positions
8sold out
1famous investor
$0.31avg. 13F price*
At the end of Q4 2024, 31 institutions reported holding Starling Oncology Inc. (STLN) in their 13F filings, down 3 from Q3 2024. 5 opened new positions and 8 sold out. The largest holders were Deerfield Management Company, L.P. ($1.0M), Tiff Advisory Services, LLC ($921K) and Cincinnati Insurance Co. ($629K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Starling Oncology Inc.
- Filed as
- THE ONCOLOGY INSTITUTE INC (Q4 2024)
- CUSIP
- 68236X100
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $67K |
| Exits | 8 | $2.5M |
All 13F filers, Q3 2024 → Q4 2024: 1,115,098 shares bought and 6,990,973 shares sold, net −5,875,875 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 31 holders
| Deerfield Management Company, L.P. | 0.02% | No change | 3,360,052 | $1.0M |
| Tiff Advisory Services, LLC | 0.30% | Add +13.2% | 2,979,141 | $921K |
| Cincinnati Insurance Co. | 0.01% | No change | 2,034,045 | $629K |
| Vanguard Group Inc. | 0.00% | Reduce -1.6% | 1,754,386 | $542K |
| Balyasny Asset Management L.P. | 0.00% | No change | 1,725,562 | $533K |
| FreeGulliver LLC | 0.10% | Add +219.3% | 600,747 | $186K |
| Quattro Financial Advisors LLC | 0.03% | No change | 162,724 | $113K |
| Geode Capital Management, LLC | 0.00% | Reduce -8.6% | 347,347 | $107K |
| FourWorld Capital Management LLC | 0.04% | No change | 257,000 | $79K |
| BlackRock, Inc. | 0.00% | Add +0.3% | 253,591 | $78K |
| Renaissance Technologies | 0.00% | Add +7.1% | 182,000 | $56K |
| Virtu Financial LLC | 0.00% | New | 131,759 | $41K |
| Jane Street Group, LLC | 0.00% | Add +613.6% | 127,659 | $39K |
| Bank of New York Mellon Corp | 0.00% | No change | 125,141 | $39K |
| State Street Corp. | 0.00% | No change | 101,300 | $31K |
| Saba Capital Management, L.P. | 0.00% | No change | 94,264 | $29K |
| Lee Financial Co | 0.00% | No change | 81,362 | $25K |
| HighTower Advisors, LLC | 0.00% | No change | 81,362 | $25K |
| Fielder Capital Group LLC | 0.01% | No change | 70,192 | $22K |
| Northern Trust Corp. | 0.00% | No change | 64,902 | $20K |
| UBS Group AG | 0.00% | New | 61,961 | $19K |
| XTX Topco Ltd | 0.00% | Add +48.4% | 37,250 | $12K |
| Morgan Stanley | 0.00% | No change | 30,392 | $9K |
| Scientech Research LLC | 0.00% | New | 21,198 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +53.9% | 13,540 | $4K |
| AMG National Trust Bank | 0.00% | No change | 10,000 | $3K |
| Bank of America Corp. | 0.00% | Add +7.8% | 2,918 | $902 |
| Citigroup Inc. | 0.00% | Add +2436.0% | 634 | $196 |
| JPMorgan Chase & Co. | 0.00% | Reduce -2.9% | 166 | $51 |
| BNP Paribas Financial Markets | 0.00% | New | 5 | $2 |
| Capital Advisors, Ltd. LLC | 0.00% | New | 1,219 | $0 |
"% of holder's portfolio" is STLN's weight in each manager's 13F, not the share of Starling Oncology Inc. the manager owns.